Medical Weight Loss
We use use tirzepatide for effective weight management. We deliver a comprehensive weight management plan that includes a reduced-calorie diet and increased physical activity.
What is Tirzepatide?
Tirzepatide: Tirzepatide is an injectable medicine used to treat adults for several conditions. Combines GLP-1 and GIP (glucose-dependent insulinotropic peptide) agonists. Primarily approved for Type 2 diabetes but shows significant weight-loss effects.
Here’s a simple breakdown of what it is and what it does.
Tirzepatide is FDA-approved for
Chronic Weight Management
It is used to help adults with obesity, or who are overweight with other weight-related health problems (like high blood pressure or high cholesterol), to lose weight and keep it off.
How Do These Medications Work for Weight Loss?
Appetite Suppression: Reduce hunger and cravings by acting on brain regions regulating satiety.
Slowed Digestion: Delay gastric emptying, making you feel full longer after meals.
Improved Insulin Sensitivity: Enhance glucose regulation, which supports fat loss and metabolic health.
Semaglutide Vs Tirzepatide
Feature
Semaglutide (Wegovy)
Tirzepatide (Mounjaro)
FAQ
What is Tirzepatide?
Tirzepatide is an injectable prescription medication used for chronic weight management. It's a "first-in-class" drug that mimics two different natural hormones involved in appetite control and metabolism.
How does Tirzepatide work for weight loss?
Tirzepatide is a dual GIP and GLP-1 receptor agonist. In simple terms, it works by:
Slowing Digestion: It slows down how quickly food leaves your stomach, making you feel full longer.
Reducing Appetite: It sends signals to the brain that you are full and satisfied, which reduces hunger and food cravings.
Improving Metabolism: It helps the body's pancreas release insulin when blood sugar is high and reduces the amount of sugar produced by the liver.
This combined action helps you eat fewer calories and improves your body's metabolic function.
How is Tirzepatide different from semaglutide (Ozempic/Wegovy)?
Both are in the same class of "incretin mimetic" drugs, but there's one key difference:
Semaglutide (Ozempic/Wegovy) is a GLP-1 agonist.
Tirzepatide (Zepbound/Mounjaro) is a dual agonist, targeting both GLP-1 and GIP.
Because it targets two hormone pathways, tirzepatide is considered by many to be more potent and has shown higher average weight loss in clinical trials compared to semaglutide.
Who Is Eligible for These Programs?
According to FDA guidelines, tirzepatide is approved for adults who are:
Obese (with a BMI of 30 or higher), OR
Overweight (with a BMI of 27 or higher) AND have at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes.
It is intended to be used along with a reduced-calorie diet and increased physical activity.
How much weight can I expect to lose?
This varies for every individual, but clinical trials have shown very significant results.
In the main SURMOUNT-1 study for Zepbound, participants taking the highest dose (15 mg) lost an average of 22.5% of their starting body weight over 72 weeks (about 1.5 years). On average, this was about 52 pounds.
What are the most common side effects?
The most common side effects are gastrointestinal. They are most common when first starting the medication or after a dose increase.
Nausea
Diarrhea
Constipation
Vomiting
Decreased appetite
Stomach (abdominal) pain or indigestion
Burping
Medical Weight Loss
Book an appointment today and get started with a comprehensive weight management plan sustained a reduced-calorie diet and increased physical activity.
Reviews
Don’t just take our word for it